当前位置: 首页 >> 检索结果
621. Cross-cultural adaptation and preliminary diagnostic performance assessment of the psoriasis epidemiology screening tool (PEST) questionnaire in Spanish.
作者: Juan Pablo Vinicki.;Karin N Saravia.;Nadia S Reta.;Erika Kornoski.;Maria S Piatis.;Philip S Helliwell.
来源: Rheumatology (Oxford). 2026年65卷1期
To perform the cross-cultural adaptation of the psoriasis epidemiology screening tool (PEST) questionnaire into Spanish (PEST-S) and conduct a preliminary exploratory assessment of its discriminative ability to identify PsA among patients with psoriasis (Ps), OA, or both.
622. Exploring the genetic interaction between ERAP1/ERAP2 and HLA-B*52:01 in Takayasu arteritis.
作者: Desiré Casares-Marfil.;Güher Saruhan-Direskeneli.;Peter C Grayson.;Enrico Tombetti.;Lindi Jiang.;Peter A Merkel.;Haner Direskeneli.;Amr H Sawalha.
来源: Rheumatology (Oxford). 2026年65卷1期
Takayasu arteritis is a rare vasculitis characterized by inflammation of large arteries. Given the robust genetic association with HLA-B*52:01, it was recently proposed to classify Takayasu arteritis within the spectrum of MHC-I-opathies. Although genetic associations in ERAP1 and ERAP2 have been described in several MHC-I-opathies, their role in Takayasu arteritis remains unclear. This study investigated the genetic interaction between ERAP1/ERAP2 and HLA-B*52:01 in Takayasu arteritis.
623. Secukinumab in active lupus nephritis: results from a phase III randomized, placebo-controlled study (SELUNE) and an open-label extension study.
作者: Ming-Hui Zhao.;Fidencio Cons Molina.;Gustavo Aroca.;Maria G Tektonidou.;Anubhav Mathur.;Radhika Tangadpalli.;Rui Sun.;Ruvie Martin.;Pascale Pellet.;Thao Ngoc Phuong Huynh.
来源: Rheumatology (Oxford). 2026年65卷1期
The objective of this study was to evaluate the efficacy and safety of s.c. secukinumab 300 mg combined with standard of care (SoC) in adult patients with active LN.
625. The impact of familial autoimmunity and familial lupus on the clinical presentations and disease outcomes of SLE patients in the United Arab Emirates.
作者: Afra Al Dhaheri.;Hiba Alblooshi.;Anjali Bharathan.;Asma Alneyadi.;Maryam Al Ali.;Amna Alzaabi.;Jalal Trad.;Satish Chandrasekhar Nair.;Najla Aljaberi.
来源: BMC Rheumatol. 2025年9卷1期118页
The presentation and outcomes of Systemic lupus erythematosus (SLE) are influenced by ethnicity and genetic background. The United Arab Emirates (UAE) is one of the leading countries of SLE per recent reports. In this study, we evaluated the effect of positive family history (FHx) of SLE and autoimmunity on clinical presentations and disease outcomes.
626. Text-based messaging to support rheumatoid arthritis care: an analysis of frequency and content of text-messages.
作者: Melissa Sipley.;Saania N Zafar.;Manuel Ester.;Glen Hazlewood.;Kiran Dhiman.;Alexandra Charlton.;Karen L Then.;Erika Dempsey.;Richard Lester.;Alison M Hoens.;Diane Lacaille.;Sarah Sloss.;Cheryl Barnabe.;Dianne Mosher.;Claire E H Barber.
来源: BMC Rheumatol. 2025年9卷1期119页
Text-based messaging support can improve rheumatoid arthritis (RA) care delivery by connecting patients with healthcare providers (HCPs) in an efficient and convenient manner. However, the nature and appropriateness of patient messaging in this new care model are unknown. The aim of this study was to (1) analyze the frequency and nature of text messages patients sent to their HCPs, and (2) to identify patient characteristics associated with higher texting frequency in a pilot of a text-based messaging (using the WelTel platform) added to usual rheumatology care.
630. The risk of cardiovascular events following treatment for psoriatic arthritis with a biological agent.
作者: Chung-Yuan Hsu.;Shang-Hong Lin.;Yu-Jih Su.;Ming-Lung Tsai.;Yuan Lin.;Ning-I Yang.;Tien-Ming Chan.;Tien-Hsing Chen.
来源: Rheumatology (Oxford). 2025年
Psoriatic arthritis (PsA) increases cardiovascular disease risk. Emerging evidence suggests biologic Disease-Modifying Antirheumatic Drugs (DMARDs) may offer protective effects, though their advantage over conventional therapy remains under investigation.
631. Long-term renal outcomes, cardiovascular events and severe infections in patients with lupus nephritis: MassiLUP cohort 2001-2022.
作者: Bérangère Goupille.;Noémie Resseguier.;Julia Torrents.;Stanislas Bataille.;Julie Beaume.;Mickaël Bobot.;Philippe Brunet.;Stéphane Burtey.;Alice Corthier.;Julien Faraut.;Marion Sallee.;Laurent Chiche.;Laurent Daniel.;Noémie Jourde-Chiche.
来源: Rheumatology (Oxford). 2026年65卷1期
Few recent epidemiological data are available on the risks of chronic kidney disease (CKD), cardiovascular events and infections, in patients with LN, even though these data are crucial for guiding therapeutic decisions. We conducted a cohort study with the aim of evaluating survival without CKD and adverse events in patients with LN.
632. Association of diastolic dysfunction with myocardial tissue characteristics assessed by multi-parameter cardiac magnetic resonance in patients with idiopathic inflammatory myopathy.
作者: Simeng Wang.;Hao Ling.;Jianqun Yu.;Wenzhang He.;Xue Li.;Yinqiu Wang.;Linyan Huang.;Jierui Zheng.;Yucheng Chen.;Liqing Peng.
来源: Rheumatology (Oxford). 2026年65卷1期
This study aimed to investigate associations between left ventricular (LV) diastolic dysfunction and myocardial tissue characteristics in idiopathic inflammatory myopathy (IIM) using multi-parameter cardiac magnetic resonance.
633. Avacopan as an add-on therapy in a paediatric patient with new-onset granulomatosis with polyangiitis and acute kidney injury: a case report.
作者: Robin Mørk.;Pernille Bøyesen.;Ingvild Andrea Kindem.;Jacob Lilleby.;Ragnar Gunnarsson.;Øyvind Molberg.;Vibke Lilleby.
来源: Rheumatology (Oxford). 2026年65卷1期 634. Global prevalence of metabolic syndrome in patients with Rheumatoid arthritis: a systematic review and meta-analysis.
作者: Maryam Jafari.;Kishan Patel.;Abinash Mahapatro.;Bita Amirian.;Casra Saeedi.;Satabdi Sahu.;Mohit Mirchandani.;Herby Jeanty.;Elan Mohanty.;Nakka Raghuma.;Saisree Reddy Adla Jala.;Shika M Jain.;Pavan Devulapally.;Rahman Hameed Mohammed Abdul.;Pegah Rashidian.;Negin Letafatkar.;Farahnaz Joukar.;Forough Heidarzad.;Mohammad-Javad Khosousi.;Mohammad Amin Karimi.;Seyyed Mohammad Hashemi.;Ehsan Amini-Salehi.
来源: BMC Rheumatol. 2025年9卷1期116页
Rheumatoid arthritis (RA) is a chronic autoimmune disorder that increases the risk of systemic complications, particularly metabolic syndrome (MetS). MetS, defined by central obesity, hypertension, hyperglycemia, and dyslipidemia, not only raises cardiovascular risk but also worsens the prognosis of RA. This meta-analysis aimed to estimate the global prevalence of MetS in RA patients and identify clinical factors contributing to its occurrence.
635. Diabetes mellitus and cardiac disease as key predictors of rituximab-induced acute thrombocytopenia in ANCA-associated vasculitis.
作者: Satoshi Akao.;Masaru Shimizu.;Kazushi Maruo.;Hiromitsu Asashima.;Yuya Kondo.;Ayako Ohyama.;Saori Abe.;Ayako Kitada.;Haruka Miki.;Hiroto Tsuboi.;Satoshi Omura.;Daiki Nakagomi.;Yoshiyuki Abe.;Makoto Wada.;Naoho Takizawa.;Atsushi Nomura.;Yuji Kukida.;Naoya Kondo.;Hirosuke Takagi.;Koji Endo.;Shintaro Hirata.;Naoto Azuma.;Tohru Takeuchi.;Shoichi Fukui.;Kazuro Kamada.;Ryo Yanai.;Yusuke Matsuo.;Yasuhiro Shimojima.;Ryo Nishioka.;Ryota Okazaki.;Tomoaki Takata.;Mayuko Moriyama.;Ayuko Takatani.;Yoshia Miyawaki.;Tsuyoshi Shirai.;Hiroaki Dobashi.;Takafumi Ito.;Toshihiko Takada.;Yutaka Kawahito.;Toshiko Ito-Ihara.;Takashi Kida.;Nobuyuki Yajima.;Takashi Kawaguchi.;Isao Matsumoto.
来源: Rheumatology (Oxford). 2026年65卷1期
Rituximab (RTX) is a key treatment for ANCA-associated vasculitis (AAV), but RTX-induced acute thrombocytopenia (RIAT) remains a concern. We aimed to evaluate the risk and risk factors of RIAT in patients with AAV undergoing RTX induction therapy.
636. Comment on: Diagnostic delay in patients from the International Map of Axial Spondyloarthritis: geographic, sociodemographic and disease-related factors.
作者: Maria Antonietta Mazzei.;Francesca Martini.;Cristian Sica.;Luca Cantarini.
来源: Rheumatology (Oxford). 2026年65卷1期 637. Tubulointerstitial inflammation driving interstitial fibrosis and tubular atrophy predicts poor renal outcome in refractory lupus nephritis.
作者: Yevgeniya Gartshteyn.;Shuwei Wang.;Laura Geraldino-Pardilla.;Adam Mor.;Vivette D D'Agati.;Robert Winchester.
来源: Rheumatology (Oxford). 2026年65卷1期
Interstitial fibrosis and tubular atrophy (IF/TA) predicts end-stage kidney disease (ESKD) in lupus nephritis (LN). Repeat kidney biopsies were evaluated to identify variables driving progression of IF/TA and ESKD.
|